Diabetes

Genetic variants tied to type 1 diabetes heterogeneity

(HealthDay)—Transcription factor 7 like 2 (TCF7L2) genetic variants contribute to phenotypic heterogeneity of type 1 diabetes, according to a study published online Oct. 12 in Diabetes Care.

Diabetes

Higher β-blocker dose linked to lower mortality risk

(HealthDay)—An increased β-blocker dose is associated with a greater prognostic advantage in patients with chronic heart failure (CHF) and diabetes than in those with CHF but no diabetes, according to a study published ...

Diabetes

Spinal cord stimulation may reduce neuropathic pain

(HealthDay)—Spinal cord stimulation (SCS) effectively reduces chronic pain symptoms in individuals with painful diabetic polyneuropathy (PDPN), according to a study published online Nov. 6 in Diabetes Care.

Diabetes

First-line metformin use for DM up; sulfonylurea use down

(HealthDay)—Among patients with type 2 diabetes initiating antidiabetes drugs (ADDs), first-line use of metformin has increased since 2005, while sulfonylureas have remained the most popular second-line agent, according ...

Diabetes

Leisure time exercise linked to reduced mortality in T1DM

(HealthDay)—For patients with type 1 diabetes, including those with chronic kidney disease (CKD), leisure-time physical activity (LTPA) is associated with reduced risk of all-cause mortality, according to a study published ...

Diabetes

Drop in incidence of end-stage renal disease due to diabetes

(HealthDay)—The incidence of end-stage renal disease (ESRD) with diabetes listed as the primary cause (ESRD-D) decreased across the United States from 2000 to 2014, according to a study published online Nov. 2 in Morbidity ...

page 39 from 40